Endurant Capital Management as of March 31, 2023
Portfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 49 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| BioMarin Pharmaceutical (BMRN) | 12.8 | $25M | 256k | 97.24 | |
| Becton, Dickinson and (BDX) | 9.8 | $19M | 77k | 247.54 | |
| Anthem (ELV) | 8.8 | $17M | 37k | 459.81 | |
| Sabra Health Care REIT (SBRA) | 6.9 | $13M | 1.2M | 11.50 | |
| Laboratory Corp Amer Hldgs Com New (LH) | 5.3 | $10M | 45k | 229.42 | |
| Qiagen Nv Shs New | 4.2 | $8.2M | 179k | 45.93 | |
| Cigna Corp (CI) | 3.6 | $7.1M | 28k | 255.53 | |
| Astrazeneca Sponsored Adr (AZN) | 3.5 | $6.8M | 97k | 69.41 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 3.5 | $6.7M | 762k | 8.85 | |
| Icon SHS (ICLR) | 2.9 | $5.7M | 27k | 213.59 | |
| Moderna (MRNA) | 2.9 | $5.5M | 36k | 153.58 | |
| Merck & Co (MRK) | 2.7 | $5.3M | 50k | 106.39 | |
| Avantor (AVTR) | 2.4 | $4.8M | 226k | 21.14 | |
| Bio Rad Labs Cl A (BIO) | 2.3 | $4.4M | 9.2k | 479.02 | |
| Insmed Com Par $.01 (INSM) | 2.0 | $3.9M | 230k | 17.05 | |
| Tenet Healthcare Corp Com New (THC) | 1.8 | $3.6M | 60k | 59.42 | |
| Selecta Biosciences (RNAC) | 1.5 | $3.0M | 2.2M | 1.39 | |
| Pfizer (PFE) | 1.5 | $3.0M | 73k | 40.80 | |
| Ocular Therapeutix (OCUL) | 1.4 | $2.7M | 513k | 5.27 | |
| McKesson Corporation (MCK) | 1.3 | $2.6M | 7.3k | 356.05 | |
| Ptc Therapeutics I (PTCT) | 1.3 | $2.6M | 53k | 48.44 | |
| Dex (DXCM) | 1.3 | $2.6M | 22k | 116.18 | |
| Argenx Se Sponsored Adr (ARGX) | 1.2 | $2.3M | 6.1k | 372.58 | |
| Peak (DOC) | 1.1 | $2.2M | 101k | 21.97 | |
| Dentsply Sirona (XRAY) | 1.1 | $2.2M | 56k | 39.28 | |
| Thermo Fisher Scientific (TMO) | 1.1 | $2.2M | 3.7k | 576.37 | |
| Centene Corporation (CNC) | 1.0 | $1.9M | 30k | 63.21 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.9 | $1.8M | 1.7M | 1.09 | |
| Bluebird Bio (BLUE) | 0.9 | $1.7M | 525k | 3.18 | |
| Iveric Bio | 0.8 | $1.6M | 65k | 24.33 | |
| Gritstone Oncology Ord (GRTS) | 0.8 | $1.5M | 541k | 2.78 | |
| AmerisourceBergen (COR) | 0.8 | $1.5M | 9.2k | 160.11 | |
| Encompass Health Corp (EHC) | 0.7 | $1.4M | 27k | 54.10 | |
| Uniqure Nv SHS (QURE) | 0.7 | $1.4M | 71k | 20.14 | |
| Zoetis Cl A (ZTS) | 0.7 | $1.4M | 8.4k | 166.44 | |
| Baxter International (BAX) | 0.7 | $1.4M | 35k | 40.56 | |
| ResMed (RMD) | 0.7 | $1.4M | 6.3k | 218.99 | |
| Zimmer Holdings (ZBH) | 0.6 | $1.2M | 9.3k | 129.20 | |
| Viking Therapeutics Call Option (VKTX) | 0.5 | $957k | 58k | 16.65 | |
| Aclaris Therapeutics (ACRS) | 0.3 | $679k | 84k | 8.09 | |
| Catalent (CTLT) | 0.3 | $601k | 9.1k | 65.71 | |
| Iovance Biotherapeutics (IOVA) | 0.3 | $492k | 81k | 6.11 | |
| Coherus Biosciences (CHRS) | 0.2 | $444k | 65k | 6.84 | |
| 89bio (ETNB) | 0.2 | $298k | 20k | 15.23 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.1 | $291k | 21k | 14.01 | |
| Bioxcel Therapeutics (BTAI) | 0.1 | $217k | 12k | 18.66 | |
| Biodesix (BDSX) | 0.1 | $211k | 113k | 1.86 | |
| Addex Therapeutics Sponsored Ads | 0.1 | $114k | 121k | 0.95 | |
| Athenex Com New (ATNXQ) | 0.0 | $57k | 43k | 1.33 |
